Review paper: preclinical models of psoriasis (Q37202513)

18 August 2017

1 reference

title

Review paper: preclinical models of psoriasis (English)

1 reference

18 August 2017

D M Danilenko

1

1 reference

18 August 2017

publication date

1 July 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

45

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

563-575

1 reference

The pathophysiology of psoriasis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Psoriasiform dermatitis susceptibility in Itgb2(tm1Bay) PL/J mice requires low-level CD18 expression and at least two additional loci for progression to severe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Interleukin 20: discovery, receptor identification, and role in epidermal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Persistence of pathogenic CD4+ Th1-like cells in vivo in the absence of IL-12 but in the presence of autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

CD4+ T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Pathogenesis and therapy of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Animal models of psoriasis - what can we learn from them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Murine psoriasis-like disorder induced by naive CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Dermal injection of immunocytes induces psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

The Development and Characterization of an In Vitro Model of Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

Etiopathogenesis of ankylosing spondylitis and reactive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-563

21 January 2018

Identifiers

DOI

10.1354/VP.45-4-563

1 reference

release_soiijohq7vda3giv4h47lwgvpu

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/soiijohq7vda3giv4h47lwgvpu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference